These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33450404)

  • 1. Commentary: SARS-CoV-2 vaccines and cancer patients.
    Corti C; Curigliano G
    Ann Oncol; 2021 Apr; 32(4):569-571. PubMed ID: 33450404
    [No Abstract]   [Full Text] [Related]  

  • 2. Repurposing CD8
    Gujar S; Pol JG; Kim Y; Kroemer G
    Oncoimmunology; 2020 Jul; 9(1):1794424. PubMed ID: 32923158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 vaccines: call for global push to maintain efficacy.
    Stöhr K; Cox N
    Nature; 2021 Feb; 590(7844):36. PubMed ID: 33531701
    [No Abstract]   [Full Text] [Related]  

  • 4. SARS-CoV-2 candidate vaccines - composition, mechanisms of action and stages of clinical development.
    Rodriguez-Coira J; Sokolowska M
    Allergy; 2021 Jun; 76(6):1922-1924. PubMed ID: 33340417
    [No Abstract]   [Full Text] [Related]  

  • 5. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Facharztmagazine R
    MMW Fortschr Med; 2021 Apr; 163(7):66. PubMed ID: 33844237
    [No Abstract]   [Full Text] [Related]  

  • 9. [Not Available].
    Red
    MMW Fortschr Med; 2020 Apr; 162(7):56. PubMed ID: 32291653
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progress in the development of coronavirus disease 2019 vaccine].
    Hu LF; Zhu MY; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2021 Feb; 59(2):150-153. PubMed ID: 33548966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system.
    de Queiroz NMGP; Marinho FV; Chagas MA; Leite LCC; Homan EJ; de Magalhães MTQ; Oliveira SC
    Microbes Infect; 2020; 22(10):515-524. PubMed ID: 32961274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
    Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
    J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccines in patients with cancer.
    Trapani D; Curigliano G
    Lancet Oncol; 2021 Jun; 22(6):738-739. PubMed ID: 34087120
    [No Abstract]   [Full Text] [Related]  

  • 15. New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Ura T; Yamashita A; Mizuki N; Okuda K; Shimada M
    Vaccine; 2021 Jan; 39(2):197-201. PubMed ID: 33279318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge.
    Yahalom-Ronen Y; Tamir H; Melamed S; Politi B; Shifman O; Achdout H; Vitner EB; Israeli O; Milrot E; Stein D; Cohen-Gihon I; Lazar S; Gutman H; Glinert I; Cherry L; Vagima Y; Lazar S; Weiss S; Ben-Shmuel A; Avraham R; Puni R; Lupu E; Bar-David E; Sittner A; Erez N; Zichel R; Mamroud E; Mazor O; Levy H; Laskar O; Yitzhaki S; Shapira SC; Zvi A; Beth-Din A; Paran N; Israely T
    Nat Commun; 2020 Dec; 11(1):6402. PubMed ID: 33328475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Factors in COVID-19 Therapeutics and Vaccines.
    Kurtovic L; Beeson JG
    Trends Immunol; 2021 Feb; 42(2):94-103. PubMed ID: 33402318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COVID-19 vaccination of cancer patients].
    Brustugun OT; Heggelund L
    Tidsskr Nor Laegeforen; 2021 Feb; 141(3):. PubMed ID: 33624982
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays.
    Demey B; Daher N; François C; Lanoix JP; Duverlie G; Castelain S; Brochot E
    J Infect; 2020 Aug; 81(2):e6-e10. PubMed ID: 32389784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible method for the production of a Covid-19 vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Mar; 186(12):388. PubMed ID: 32221001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.